BharatNotes What is Medical Devices Regulation?
Medical Devices Regulation refers to the legal and institutional system controlling how medical devices are classified, approved, manufactured, imported, sold and monitored in India. The lead regulator is the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), acting under the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017. Devices are treated as a category of "drugs" for regulatory purposes.
Risk-Based Classification
The Medical Devices Rules, 2017 adopt a four-tier, risk-based classification aligned with the Global Harmonisation Task Force (GHTF) approach. Higher risk attracts stricter pre-market and post-market control.
| Class | Risk level | Illustrative examples |
|---|---|---|
| A | Low | Surgical dressings, examination gloves, thermometers |
| B | Low-moderate | Hypodermic needles, suction equipment |
| C | Moderate-high | Ventilators, bone-fixation plates, certain implants |
| D | High | Heart valves, pacemakers, implantable devices |
How the Framework Evolved
Until 11 February 2020, only about 37 categories of devices were notified as drugs. Two gazette notifications of 11 February 2020 redefined "medical device" and amended the rules so that all medical devices came under regulation from 1 April 2020, phased by risk:
- Class A and B non-notified devices came under the full licensing regime from 1 October 2022.
- Class C and D non-notified devices came under licensing from 1 October 2023 (CDSCO circular of 12 April 2023; a six-month transition relief was given via a circular of 12 October 2023 for those who had applied before 30 September 2023).
National Medical Devices Policy, 2023
Approved by the Union Cabinet on 26 April 2023 (published 2 May 2023), the policy targets making India a global leader, aiming for a 10-12 percent share of the global market and growth of the sector from roughly US$ 11 billion to about US$ 50 billion by 2030 (PIB, 26-Apr-2023). It works across six areas: regulatory streamlining (a single-window clearance system), enabling infrastructure, R&D and innovation, investment attraction, human-resource development and brand positioning. Four Medical Device Parks are supported in Himachal Pradesh, Madhya Pradesh, Tamil Nadu and Uttar Pradesh (₹100 crore central assistance each).
Significance and Current Status
India's medical-device market was valued at roughly US$ 11-15 billion (2023) with import dependence estimated at 70-80 percent (IBEF/PIB). To cut this, the government runs a PLI Scheme for medical devices with an outlay of ₹3,420 crore (FY 2020-21 to FY 2027-28), giving 5 percent incentive on incremental sales in segments such as imaging, cardio-respiratory, implants and renal-care devices (PIB; PRS). Together, the Rules, the 2023 Policy and PLI form a coherent push toward quality assurance and self-reliance.
UPSC Angle
Treat this as a GS3 governance-plus-economy theme: know the regulator (CDSCO/DCGI), the statute and rules, the four risk classes, and the indigenisation levers (Policy 2023, PLI, device parks). It links to Atmanirbhar Bharat, healthcare access and regulatory capacity, and pairs well with current-affairs tracking on Ujiyari.com.
